EBITDA

In Q3, the company registered a net profit of Rs 914 crores Sun Pharmaceutical Industries reported financials for the third…

Consolidated EBITDA was at ₹1,851 million Strides Pharma Science has announced its Q3FY20 results. In Q3FY20, the consolidated…

EBITDA at Rs 480 crores, up 18 per cent

EBITDA up 10 per cent to Rs 173 crores; the company also separates the roles of managing director and chairperson

Net profit last year was 646 million francs versus 563 million in 2018, the Basel-based company said. Sales rose 6.8 per cent to…

The total production volume of the company during the quarter was 94218 MT as compared to 102442 MT during Sept 2018 quarter and…

Company posted profit after tax at Rs. 95 crores

In Q2 FY17, EBITDA is at Rs 6.4 billion and profit after tax at Rs 2.9 billion

Revenue from operations grew 14 per cent at Rs 426 crores against Rs 372 crores in Q4 FY 2016

Revenue grows 31 per cent to Rs 334 crore; EBITA up by 23 per cent to Rs 106 crore